Patterns and clinical relevance of antibody responses during adalimumab therapy

RDF 

 
This item is provided by the institution :
Hellenic Gastroenterologiki Company
Repository :
Annals of Gastroenterology
see item page
in the web site of the repository *
share



Semantic enrichment/homogenization by EKT

2010 (EN)
Patterns and clinical relevance of antibody responses during adalimumab therapy (EN)

Katsanos, K.H.
Vagias, I.
Tsianos, V.
Tsianos, E.V.

All biologic therapies have the potential to induce immunogenicity. Homology reduces antigenicity, but ‘humanization’ does not equate with homology and human antibodies may be also immunogenic. Despite of its proved efficacy in Crohn’s disease patients, adalimumab carries the potential of molecule-specific toxicities which may be expressed with several types of antibody responses, and which are usually divided as allergic, autoimmunity and immunogenicity phenomena. (EN)

Ελληνική Γαστροεντερολογική Εταιρία (EL)
Hellenic Gastroenterologiki Company (EN)

2010-07-09


Annals of Gastroenterology (EN)

Annals of Gastroenterology; Volume 23, No 3 (2010); 165 - 171 (EN)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)